argenx (ADR) (ARGX)
Develops antibody medicines for severe autoimmune diseases around the VYVGART franchise.
$959.25
vs last close−4.54 (−0.47%)
Something off on this page? Send us feedback.
EPSReportedEstimate
Jun '23Oct '23May '24Oct '24May '25Oct '25May '26Jul '26
Reported$0.82−$1.25−$1.04$1.39$2.58$5.18$5.90$7.32
Estimate—−$1.54−$0.71$0.10$2.32$4.37$5.16$6.27
Surprise—+18.8%−46.5%+1,290.0%+11.2%+18.5%+14.3%+16.7%
RevenueReportedEstimate
Jun '23Oct '23May '24Oct '24May '25Oct '25May '26Jul '26
Reported−$258.0M$510.9M$329.8M$401.0M$573.2M$948.0M$3.21B$2.82B
Estimate—$279.8M$563.9M$665.1M$861.8M$1.28B$1.45B$1.88B
Surprise—+82.6%−41.5%−39.7%−33.5%−25.7%+121.8%+49.8%
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Mar 2027 | $8.37 | — | — |
| Jul 2026 | $6.27 | $7.32 | +16.7% |
| May 2026 | $5.16 | $5.90 | +14.3% |
| Oct 2025 | $4.37 | $5.18 | +18.5% |
| May 2025 | $2.32 | $2.58 | +11.2% |
| Oct 2024 | |||
| May 2024 | |||
| Oct 2023 | |||
| Jun 2023 | |||
| May 2023 | |||
| Jul 2022 | |||
| Mar 2022 | |||
| Oct 2021 | |||
| May 2021 | |||
| Oct 2020 | |||
| Mar 2020 | |||
| Oct 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Oct 2018 | |||
| May 2018 | |||
| Oct 2017 | |||
| May 2017 | |||
| Oct 2016 | |||
| Jun 2016 | |||
| May 2016 | |||
| Nov 2015 | |||
| Jun 2015 | |||
| May 2015 | |||
| Dec 2014 | |||
| Nov 2014 | |||
| Jun 2014 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Mar 4, 2027 | $8.37 | — | — | $3.35B | — | — | — |
| Jul 23, 2026 | $6.27 | $7.32 | +16.7% | $1.88B | $2.82B | +49.8% | +8.6% |
| May 7, 2026 | $5.16 | $5.90 | +14.3% | $1.45B | $3.21B | +121.8% | −2.5% |
| Oct 30, 2025 | $4.37 | $5.18 | +18.5% | $1.28B | $948.0M | −25.7% | −0.2% |
| May 8, 2025 | $2.32 | $2.58 | +11.2% | $861.8M | $573.2M | −33.5% | −8.6% |
| Oct 31, 2024 | |||||||
| May 9, 2024 | |||||||
| Oct 31, 2023 | |||||||
| Jun 21, 2023 | |||||||
| May 4, 2023 | |||||||
| Jul 28, 2022 | |||||||
| Mar 21, 2022 | |||||||
| Oct 28, 2021 | |||||||
| May 14, 2021 | |||||||
| Oct 22, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Oct 24, 2019 | |||||||
| Aug 1, 2019 | |||||||
| May 9, 2019 | |||||||
| Oct 25, 2018 | |||||||
| May 9, 2018 | |||||||
| Oct 26, 2017 | |||||||
| May 2, 2017 | |||||||
| Oct 27, 2016 | |||||||
| Jun 30, 2016 | |||||||
| May 11, 2016 | |||||||
| Nov 17, 2015 | |||||||
| Jun 30, 2015 | |||||||
| May 15, 2015 | |||||||
| Dec 31, 2014 | |||||||
| Nov 14, 2014 | |||||||
| Jun 30, 2014 |